世界のオピオイド誘発性便秘（OIC）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z4281
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、オピオイド誘発性便秘（OIC）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口（皮下注射））、用途別市場規模（ドラッグストア、独立型薬局、病院薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・オピオイド誘発性便秘（OIC）治療の市場動向
・企業の競争状況、市場シェア
・オピオイド誘発性便秘（OIC）治療の種類別市場規模（経口、非経口（皮下注射））
・オピオイド誘発性便秘（OIC）治療の用途別市場規模（ドラッグストア、独立型薬局、病院薬局）
・オピオイド誘発性便秘（OIC）治療の北米市場規模2016-2027（アメリカ、カナダ）
・オピオイド誘発性便秘（OIC）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・オピオイド誘発性便秘（OIC）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・オピオイド誘発性便秘（OIC）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・オピオイド誘発性便秘（OIC）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（GlaxoSmithKline、AstraZeneca、Pfizer、S.L.A. Pharma、AIKO Biotechnology、Cubist Pharmaceuticals、Salix Pharmaceuticals、Takeda Pharmaceutical）
・結論

Market Analysis and Insights: Global Opioid-Induced Constipation (OIC) Treatment Market
The global Opioid-Induced Constipation (OIC) Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Opioid-Induced Constipation (OIC) Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Opioid-Induced Constipation (OIC) Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Opioid-Induced Constipation (OIC) Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Opioid-Induced Constipation (OIC) Treatment market.

Global Opioid-Induced Constipation (OIC) Treatment Scope and Market Size
Opioid-Induced Constipation (OIC) Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Opioid-Induced Constipation (OIC) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral
Parenteral (Subcutaneous Injection)

Segment by Application
Drug Store
Independent Pharmacies
Hospital Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral
1.2.3 Parenteral (Subcutaneous Injection)
1.3 Market by Application
1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Drug Store
1.3.3 Independent Pharmacies
1.3.4 Hospital Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2016-2027)
2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions
2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Opioid-Induced Constipation (OIC) Treatment Industry Dynamic
2.3.1 Opioid-Induced Constipation (OIC) Treatment Market Trends
2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers
2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges
2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue
3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2016-2021)
3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type
4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2016-2021)
4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027)

5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application
5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2016-2021)
5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
6.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
6.2.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
6.2.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
6.3.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
6.3.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
6.3.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
6.4.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
6.4.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type
7.2.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
7.2.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application
7.3.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
7.3.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
7.3.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country
7.4.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
7.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type
8.2.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application
8.3.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region
8.4.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
9.2.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
9.3.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
9.4.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type
10.2.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application
10.3.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country
10.4.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Details
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.2.5 AstraZeneca Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.3.5 Pfizer Recent Development
11.4 S.L.A. Pharma
11.4.1 S.L.A. Pharma Company Details
11.4.2 S.L.A. Pharma Business Overview
11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.4.5 S.L.A. Pharma Recent Development
11.5 AIKO Biotechnology
11.5.1 AIKO Biotechnology Company Details
11.5.2 AIKO Biotechnology Business Overview
11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.5.5 AIKO Biotechnology Recent Development
11.6 Cubist Pharmaceuticals
11.6.1 Cubist Pharmaceuticals Company Details
11.6.2 Cubist Pharmaceuticals Business Overview
11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.6.5 Cubist Pharmaceuticals Recent Development
11.7 Salix Pharmaceuticals
11.7.1 Salix Pharmaceuticals Company Details
11.7.2 Salix Pharmaceuticals Business Overview
11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.7.5 Salix Pharmaceuticals Recent Development
11.8 Takeda Pharmaceutical
11.8.1 Takeda Pharmaceutical Company Details
11.8.2 Takeda Pharmaceutical Business Overview
11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
11.8.5 Takeda Pharmaceutical Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral
Table 3. Key Players of Parenteral (Subcutaneous Injection)
Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2016-2021)
Table 8. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
Table 10. Opioid-Induced Constipation (OIC) Treatment Market Trends
Table 11. Opioid-Induced Constipation (OIC) Treatment Market Drivers
Table 12. Opioid-Induced Constipation (OIC) Treatment Market Challenges
Table 13. Opioid-Induced Constipation (OIC) Treatment Market Restraints
Table 14. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2016-2021)
Table 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020)
Table 17. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
Table 21. Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. GlaxoSmithKline Company Details
Table 62. GlaxoSmithKline Business Overview
Table 63. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product
Table 64. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 65. GlaxoSmithKline Recent Development
Table 66. AstraZeneca Company Details
Table 67. AstraZeneca Business Overview
Table 68. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product
Table 69. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 70. AstraZeneca Recent Development
Table 71. Pfizer Company Details
Table 72. Pfizer Business Overview
Table 73. Pfizer Opioid-Induced Constipation (OIC) Treatment Product
Table 74. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 75. Pfizer Recent Development
Table 76. S.L.A. Pharma Company Details
Table 77. S.L.A. Pharma Business Overview
Table 78. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product
Table 79. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 80. S.L.A. Pharma Recent Development
Table 81. AIKO Biotechnology Company Details
Table 82. AIKO Biotechnology Business Overview
Table 83. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product
Table 84. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 85. AIKO Biotechnology Recent Development
Table 86. Cubist Pharmaceuticals Company Details
Table 87. Cubist Pharmaceuticals Business Overview
Table 88. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
Table 89. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 90. Cubist Pharmaceuticals Recent Development
Table 91. Salix Pharmaceuticals Company Details
Table 92. Salix Pharmaceuticals Business Overview
Table 93. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
Table 94. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 95. Salix Pharmaceuticals Recent Development
Table 96. Takeda Pharmaceutical Company Details
Table 97. Takeda Pharmaceutical Business Overview
Table 98. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
Table 99. Takeda Pharmaceutical Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Features
Figure 3. Parenteral (Subcutaneous Injection) Features
Figure 4. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2027
Figure 5. Drug Store Case Studies
Figure 6. Independent Pharmacies Case Studies
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Opioid-Induced Constipation (OIC) Treatment Report Years Considered
Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2020
Figure 14. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
Figure 16. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 20. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 21. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 22. United States Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 26. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 27. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 28. Germany Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2016-2027)
Figure 38. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 58. AstraZeneca Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 59. Pfizer Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 60. S.L.A. Pharma Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 61. AIKO Biotechnology Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 62. Cubist Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のオピオイド誘発性便秘治療市場規模・現状・予測（2021年-2027年）

Global Opioid Induced Constipation Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4280 2021年4月 92Pages
QYResearch社発行の本調査資料では、オピオイド誘発性便秘治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口、非経口（皮下注射））、用途別市場規模（ドラッグストア、独立型薬局、病院薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のオピオイド誘発性便秘市場規模・現状・予測（2021年-2027年）

Global Opioid-induced Constipation Market Size, Status and Forecast 2021-2027
QYR2104Z4282 2021年4月 126Pages
QYResearch社発行の本調査資料では、オピオイド誘発性便秘のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（固体、液体）、用途別市場規模（ドラッグストア、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓...

世界のオピオイド誘発性便秘市場規模・現状・予測（2021年-2027年）

世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年）

Global Opioid Induced Constipation Drugs Market Size, Status and Forecast 2021-2027
QYR2104Z4279 2021年4月 130Pages
QYResearch社発行の本調査資料では、オピオイド誘発性便秘薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ルビプロストン、臭化メチルナルトレキソン、ナルデメジン、アルビモパン、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライ...

世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年）

世界の化学療法誘発性末梢神経障害（CIPN）治療市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Peripheral Neuropathy Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1273 2021年4月 131Pages
QYResearch社発行の本調査資料では、化学療法誘発性末梢神経障害（CIPN）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（カルシウムチャネルα2-デルタリガンド、抗うつ薬、オピオイド、その他）、用途別市場規模（プラチナ剤、タキサン、...

世界の化学療法誘発性末梢神経障害（CIPN）治療市場規模・現状・予測（2021年-2027年）

世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年）

Global Chemotherapy Induced Acral Erythema (Hand-Foot Syndrome) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1271 2021年4月 94Pages
QYResearch社発行の本調査資料では、化学療法薬誘発性肢端紅斑（手足症候群）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛剤、抗炎症剤・抗浮腫剤、抗ヒスタミン剤、NSAID、経口/局所グルココルチコイド、ピリドキシン（ビタミンB...

世界の化学療法薬誘発性肢端紅斑（手足症候群）治療市場規模・現状・予測（2021年-2027年）

世界の便秘市場規模・現状・予測（2021年-2027年）

Global Constipation Market Size, Status and Forecast 2021-2027
QYR2104Z1552 2021年4月 126Pages
QYResearch社発行の本調査資料では、便秘のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（慢性特発性便秘（CIC）、過敏性腸症候群（IBS-C）、オピオイド誘発性便秘（OIC））、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要...

世界のオピオイド誘発性便秘治療市場規模・現状・予測（2021年-2027年） There are multiple drugs in the pipeline for opioid induced constipation treatment. Upon approval, these drugs will face little competition in this market which is largely untapped. There have not been many stable choices in the pharmaceutical industry for opioid induced constipation treatment over …
世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界のオピオイド誘発性便秘薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid Induced Constipation Drugs Market The global Opioid Induced Constipation Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high da…
世界のオピオイド誘発性便秘市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid-induced Constipation Market The global Opioid-induced Constipation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…
世界のオピオイド誘発性便秘市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Opioid-induced Constipation Market The global Opioid-induced Constipation market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity…